Invicta Diagnostic Limited sees change in partnership of subsidiary Porteus Pathogenius LLP
Invicta Diagnostic Limited has announced a change in the Designated Partner composition of Porteus Pathogenius LLP, a step-down subsidiary operating under its subsidiary, Porteus Medical LLP. The transition involves the cessation of one partner and the induction of another, while maintaining stable control by the intermediate holding entity.The development concerns the partnership constitution of Porteus Pathogenius LLP. According to the details provided, Porteus Medical LLP continues to hold a 51% partnership interest in Porteus Pathogenius LLP. The change involves Mr. Vishwajeet Arvind Burungale, who previously held a 49% partnership interest...